Atrion Corporation

636.48-26.52-4.00%Vol 1.42K1Y Perf 2.63%
Aug 9th, 2022 16:00 DELAYED
BID258.49 ASK1 021.99
Open636.48 Previous Close663.00
Pre-Market- After-Market636.48
 - -  - -%
Target Price
300.00 
Analyst Rating
— 0.00
Potential %
-52.87 
Finscreener Ranking
★★★+     50.51
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★     50.41
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★★     60.07
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
★★★+     47.76
Price Range Ratio 52W %
23.24 
Earnings Rating
Buy
Market Cap1.14B 
Earnings Date
8th Aug 2022
Alpha0.00 Standard Deviation0.07
Beta0.17 

Today's Price Range

636.48636.48

52W Range

585.27805.62

5 Year PE Ratio Range

26.2051.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-0.09%
1 Month
7.25%
3 Months
6.49%
6 Months
0.77%
1 Year
2.63%
3 Years
-11.39%
5 Years
2.78%
10 Years
226.49%

TickerPriceChg.Chg.%
ATRI636.48-26.5200-4.00
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
41.80
21.60
29.20
26.40
19.13
RevenueValueIndustryS&P 500US Markets
130.29M
72.58
2.29
2.20
DividendsValueIndustryS&P 500US Markets
1.21
7.80
11.38
12.60
Payout ratio40.00
Earnings HistoryEstimateReportedSurprise %
Q02 2022-5.20-
Q01 2022-4.71-
Q04 2021-4.50-
Q03 2021-4.58-
Q02 2021-4.88-
Q01 2021-4.22-
Q04 2020-4.02-
Q03 2020-3.95-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.42K
Shares Outstanding1.80K
Shares Float974.20K
Trades Count372
Dollar Volume910.53K
Avg. Volume2.79K
Avg. Weekly Volume2.21K
Avg. Monthly Volume2.41K
Avg. Quarterly Volume3.76K

Atrion Corporation (NASDAQ: ATRI) stock closed at 663 per share at the end of the most recent trading day (a 2% change compared to the prior day closing price) with a volume of 3.28K shares and market capitalization of 1.14B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 616 people. Atrion Corporation CEO is David A. Battat.

The one-year performance of Atrion Corporation stock is 2.63%, while year-to-date (YTD) performance is -5.94%. ATRI stock has a five-year performance of 2.78%. Its 52-week range is between 585.2713 and 805.62, which gives ATRI stock a 52-week price range ratio of 23.24%

Atrion Corporation currently has a PE ratio of 34.70, a price-to-book (PB) ratio of 4.72, a price-to-sale (PS) ratio of 8.88, a price to cashflow ratio of 27.10, a PEG ratio of 2.32, a ROA of 12.87%, a ROC of 13.51% and a ROE of 14.17%. The company’s profit margin is 19.13%, its EBITDA margin is 29.20%, and its revenue ttm is $130.29 Million , which makes it $72.58 revenue per share.

Of the last four earnings reports from Atrion Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Atrion Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Atrion Corporation is (0), with a target price of $300, which is -52.87% compared to the current price. The earnings rating for Atrion Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Atrion Corporation has a dividend yield of 1.21% with a dividend per share of $7.80 and a payout ratio of 40.00%.

Atrion Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.11, ATR14 : 12.73, CCI20 : 48.89, Chaikin Money Flow : -0.02, MACD : 7.46, Money Flow Index : 63.72, ROC : 5.17, RSI : 51.27, STOCH (14,3) : 66.27, STOCH RSI : 0.78, UO : 42.53, Williams %R : -33.73), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Atrion Corporation in the last 12-months were: David A. Battat (Option Excercise at a value of $2 152 000), Emile A. Battat (Option Excercise at a value of $1 856 200), Emile A. Battat (Sold 528 shares of value $361 038 ), Jeffery Strickland (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
1 (100.00 %)
Summary Rating-
0.00
-
0.00
Strong Sell
5.00

Atrion Corporation

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

CEO: David A. Battat

Telephone: +1 972 390-9800

Address: One Allentown Parkway, Allen 75002, TX, US

Number of employees: 616

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

74%26%

Bearish Bullish

58%42%


News

Stocktwits